Found: 23
Select item for more details and to access through your institution.
Cardiovascular outcome trials in obesity: A review.
- Published in:
- Obesity Reviews, 2021, v. 22, n. 1, p. 1, doi. 10.1111/obr.13112
- By:
- Publication type:
- Article
Weight loss variability with SGLT2 inhibitors and GLP‐1 receptor agonists in type 2 diabetes mellitus and obesity: Mechanistic possibilities.
- Published in:
- Obesity Reviews, 2019, v. 20, n. 6, p. 816, doi. 10.1111/obr.12841
- By:
- Publication type:
- Article
New insights into the treatment of obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2058, doi. 10.1111/dom.15077
- By:
- Publication type:
- Article
The cost‐effectiveness of dapagliflozin in treating high‐risk patients with type 2 diabetes mellitus: An economic evaluation using data from the DECLARE‐TIMI 58 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 4, p. 1020, doi. 10.1111/dom.14308
- By:
- Publication type:
- Article
Facing the Challenges for Europe - Research into Action: Liverpool European Congress of Obesity, May 12-15, 2013.
- Published in:
- Obesity Facts: The European Journal of Obesity, 2012, v. 5, n. 4, p. 629, doi. 10.1159/000342705
- By:
- Publication type:
- Article
Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome.
- Published in:
- European Heart Journal, 2004, v. 25, n. 9, p. 735, doi. 10.1016/j.ehj.2004.02.021
- By:
- Publication type:
- Article
Natriuretic peptides, body mass index and heart failure risk: Pooled analyses of SAVOR‐TIMI 53, DECLARE‐TIMI 58 and CAMELLIA‐TIMI 61.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 2, p. 260, doi. 10.1002/ejhf.3118
- By:
- Publication type:
- Article
Screening for obstructive sleep apnoea in obesity and diabetes - potential for future approaches.
- Published in:
- European Journal of Clinical Investigation, 2013, v. 43, n. 6, p. 640, doi. 10.1111/eci.12083
- By:
- Publication type:
- Article
Increases in Neuropeptide Y Content and Gene Expression in the Hypothalamus of Rats Treated with Dexamethasone Are Prevented by Insulin.
- Published in:
- Neuroendocrinology, 1993, v. 57, n. 4, p. 581, doi. 10.1159/000126410
- By:
- Publication type:
- Article
Response: Postprandial Adiponectin Revisited.
- Published in:
- Obesity (19307381), 2004, v. 12, n. 6, p. 1032, doi. 10.1038/oby.2004.127
- By:
- Publication type:
- Article
Plasma Adiponectin Increases Postprandially in Obese, but not in Lean, Subjects.
- Published in:
- Obesity (19307381), 2003, v. 11, n. 7, p. 839, doi. 10.1038/oby.2003.115
- By:
- Publication type:
- Article
Efficacy and Safety of Dapagliflozin by Baseline Insulin Regimen and Dose: Post Hoc Analyses From DECLARE-TIMI 58.
- Published in:
- Diabetes Care, 2023, v. 46, n. 1, p. 156, doi. 10.2337/dc22-1318
- By:
- Publication type:
- Article
Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial.
- Published in:
- Diabetes Care, 2022, v. 45, n. 10, p. 2350, doi. 10.2337/dc22-0382
- By:
- Publication type:
- Article
Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program.
- Published in:
- Diabetes Care, 2022, v. 45, n. 10, p. 2396, doi. 10.2337/dc21-1785
- By:
- Publication type:
- Article
A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin Versus Placebo in a Primary Cardiovascular Prevention Cohort: Analyses From DECLARE-TIMI 58.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers.
- Published in:
- Diabetes Care, 2009, v. 32, n. 9, p. 1656, doi. 10.2337/dc09-0517
- By:
- Publication type:
- Article
MRI thigh measurements predict whole‐body skeletal muscle mass in patients with type 2 diabetes: a comparison with DXA.
- Published in:
- JCSM Rapid Communications, 2022, v. 5, n. 2, p. 149, doi. 10.1002/rco2.70
- By:
- Publication type:
- Article
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Early Weight Loss with Liraglutide 3.0 mg Predicts 1-Year Weight Loss and is Associated with Improvements in Clinical Markers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency.
- Published in:
- Clinical Endocrinology, 2004, v. 60, n. 1, p. 137, doi. 10.1111/j.1365-2265.2004.01929.x
- By:
- Publication type:
- Article
The influence of growth hormone replacement on heart rate variability in adults with growth hormone deficiency.
- Published in:
- Clinical Endocrinology, 2001, v. 54, n. 6, p. 819, doi. 10.1046/j.1365-2265.2001.01267.x
- By:
- Publication type:
- Article